Considerations for viral co-infection studies in human populations.
Chin T, Foxman EF, Watkins TA, Lipsitch M.
mBio. 2024 Jun 07. e0065824. PMID: 38847531
Faculty Affiliate in the Department of Immunology and Infectious Diseases
Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Director, Center for Communicable Disease Dynamics
Epidemiology
Harvard T.H. Chan School of Public Health
I am Professor of Epidemiology with primary appointment in the Department of Epidemiology and an affiliated appointment in the Department of Immunology and Infectious Diseases, where my wet lab is located. I direct the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS program of NIH/NIGMS. I am also the Associate Director of the Interdisciplinary Concentration in Infectious Disease Epidemiology.
B.A., 1991, Philosophy
Yale University
D.Phil, 1995, Zoology
University of Oxford
Chin T, Foxman EF, Watkins TA, Lipsitch M.
mBio. 2024 Jun 07. e0065824. PMID: 38847531
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S.
J Infect Dis. 2024 Apr 30. PMID: 38687898
Lipsitch M, Grad Y.
NEJM Evid. 2024 May. 3(5):EVIDra2300271. PMID: 38815175
Lewnard JA, Mahale P, Malden D, Hong V, Ackerson BK, Lewin BJ, Link-Gelles R, Feldstein LR, Lipsitch M, Tartof SY.
medRxiv. 2024 Apr 19. PMID: 38699313
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S.
medRxiv. 2024 Apr 10. PMID: 37016669
Lipsitch M, Inglesby TV, Cicero A, Relman DA.
J Virol. 2024 Apr 16. 98(4):e0006124. PMID: 38477584
Olejarz JW, Roster KIO, Kissler SM, Lipsitch M, Grad YH.
Epidemics. 2024 Mar. 46:100750. PMID: 38394927
Richard DM, Lipsitch M.
Int J Epidemiol. 2024 Feb 01. 53(1). PMID: 38145617
Raphson L, Lipsitch M.
Epidemiology. 2024 May 01. 35(3):372-376. PMID: 38300113
Rosen JB, Arciuolo RJ, Pathela P, Boyer CB, Baumgartner J, Latash J, Malec L, Lee EH, Reddy V, King R, Edward Real J, Lipsitch M, Zucker JR.
Vaccine. 2024 Jan 25. 42(3):548-555. PMID: 38218669
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report that makes recommendations on strategies for conducting research on dangerous pathogens.
In the wake of the World Health Organization’s declaration on May 5 that it was ending the COVID global health emergency, experts acknowledged that the disease now poses much less of threat than it has over the past…
Harvard Chan School’s Alberto Ascherio and Marc Lipsitch are among 46 individuals in life sciences named to the 2023 STATUS List—a group of leaders in public health, medicine, biotechnology, and more, recognized by STAT for their contributions to…
Harvard Chan School experts offer comments and context about the coronavirus in a variety of media outlets.
Federal regulation of research on dangerous pathogens such as COVID-19 has loopholes and lacks clarity, according to experts.